Uniform Project Description (UPD) Project Narrative Format for Discretionary Grant Application Forms; Correction, 9731 [2015-03627]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 36 / Tuesday, February 24, 2015 / Notices
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
comply with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Summary of
Benefits and Coverage and Uniform
Glossary; Use: Section 2715 of the PHS
Act directs the Department of Health
and Human Services (HHS), the
Department of Labor (DOL), and the
Department of the Treasury
(collectively, the Departments), in
consultation with the National
Association of Insurance Commissioners
(NAIC) and a working group comprised
of stakeholders, to ‘‘develop standards
for use by a group health plan and a
health insurance issuer in compiling
and providing to applicants, enrollees,
and policyholders and certificate
holders a summary of benefits and
coverage explanation that accurately
describes the benefits and coverage
under the applicable plan or coverage.’’
To implement these disclosure
requirements, collection of information
requests relate to the provision of the
following: Summary of benefits and
coverage, which includes coverage
examples; a uniform glossary of health
coverage and medical terms; and a
notice of modifications. Form Number:
CMS–10407 (OMB control number
0938–1146); Frequency: Annual;
Affected Public: Private Sector—
Business or other for-profits and Notfor-profit institutions; Number of
Respondents: 126,500; Number of
Responses: 41,153,858; Total Annual
Hours: 322,411. (For policy questions
regarding this collection, contact
Heather Raeburn at 301–492–4224.)
Dated: February 18, 2015.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
tkelley on DSK3SPTVN1PROD with NOTICES
[FR Doc. 2015–03650 Filed 2–23–15; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
[OMB No.: 0970–0139]
Uniform Project Description (UPD)
Project Narrative Format for
Discretionary Grant Application
Forms; Correction
Administration for Children
and Families, HHS.
ACTION: Notice; correction.
AGENCY:
The Administration for
Children and Families published a
document in the Federal Register of
February 17, 2015, concerning a request
for comments on a proposed
information collection. The document
contained an incorrect citation.
FOR FURTHER INFORMATION CONTACT:
Christopher Beach, Senior Grants Policy
Specialist, Division of Grants Policy,
Office of Administration,
Administration for Children and
Families, telephone (202) 401–1539.
Correction: In the Federal Register of
February 17, 2015, in FR. Doc. 2015–
03144, on page 8324, in the third
column, correct the last sentence of the
‘‘Description’’ caption to read:
‘‘Guidance for the content of
information requested in the Uniform
Project Description is based in 45 CFR
75.203 and Appendix I to 45 CFR part
75.’’
SUMMARY:
Christopher Beach,
Senior Grants Policy Specialist, Office of
Administration.
[FR Doc. 2015–03627 Filed 2–23–15; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2015–D–0235]
Evaluating the Effectiveness of New
Animal Drugs for the Reduction of
Pathogenic Shiga Toxin-Producing
Escherichia coli in Cattle; Draft
Guidance for Industry; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing the
availability of a draft guidance for
industry (GFI #229) entitled ‘‘Evaluating
the Effectiveness of New Animal Drugs
for the Reduction of Pathogenic Shiga
SUMMARY:
17:31 Feb 23, 2015
Jkt 235001
Toxin-Producing E. coli in Cattle.’’ The
purpose of this document is to provide
recommendations to industry relating to
study design and describe criteria the
Center for Veterinary Medicine (CVM)
thinks are the most appropriate for the
evaluation of the effectiveness of new
animal drugs that are intended to reduce
pathogenic Shiga toxin-producing E.
coli (STEC) in cattle.
DATES: Although you can comment on
any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the Agency
considers your comment on this draft
guidance before it begins work on the
final version of the guidance, submit
either electronic or written comments
on the draft guidance by April 27, 2015.
ADDRESSES: Submit written requests for
single copies of the guidance to the
Communications Staff (HFV–12), Center
for Veterinary Medicine, Food and Drug
Administration, 7519 Standish Pl.,
Rockville, MD 20855. Send one selfaddressed adhesive label to assist that
office in processing your requests. See
the SUPPLEMENTARY INFORMATION section
for electronic access to the draft
guidance document.
Submit electronic comments on the
draft guidance to https://
www.regulations.gov. Submit written
comments to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT:
Joshua R. Hayes, Center for Veterinary
Medicine (HFV–133), Food and Drug
Administration, 7500 Standish Pl.,
Rockville, MD 20855, 240–402–0651,
Joshua.hayes@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
BILLING CODE 4120–01–P
VerDate Sep<11>2014
9731
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
FDA is announcing the availability of
a draft guidance for industry (GFI #229)
entitled ‘‘Evaluating the Effectiveness of
New Animal Drugs for the Reduction of
Pathogenic Shiga Toxin-Producing E.
coli in Cattle.’’ This draft guidance
provides recommendations to industry
relating to study design and describes
criteria CVM thinks are the most
appropriate for the evaluation of the
effectiveness of new animal drugs that
are intended to reduce pathogenic STEC
in cattle. It discusses general
considerations regarding the
development of protocols, study
conduct, animal welfare, substantial
evidence of effectiveness, experimental
parameters, nutritional content of
experimental diets, and the assessment
of drug concentrations in experimental
diets. It also discusses the studies and
analyses CVM recommends for sponsors
E:\FR\FM\24FEN1.SGM
24FEN1
]]>Agencies
[Federal Register Volume 80, Number 36 (Tuesday, February 24, 2015)]
[Notices]
[Page 9731]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-03627]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
[OMB No.: 0970-0139]
Uniform Project Description (UPD) Project Narrative Format for
Discretionary Grant Application Forms; Correction
AGENCY: Administration for Children and Families, HHS.
ACTION: Notice; correction.
-----------------------------------------------------------------------
SUMMARY: The Administration for Children and Families published a
document in the Federal Register of February 17, 2015, concerning a
request for comments on a proposed information collection. The document
contained an incorrect citation.
FOR FURTHER INFORMATION CONTACT: Christopher Beach, Senior Grants
Policy Specialist, Division of Grants Policy, Office of Administration,
Administration for Children and Families, telephone (202) 401-1539.
Correction: In the Federal Register of February 17, 2015, in FR.
Doc. 2015-03144, on page 8324, in the third column, correct the last
sentence of the ``Description'' caption to read: ``Guidance for the
content of information requested in the Uniform Project Description is
based in 45 CFR 75.203 and Appendix I to 45 CFR part 75.''
Christopher Beach,
Senior Grants Policy Specialist, Office of Administration.
[FR Doc. 2015-03627 Filed 2-23-15; 8:45 am]
BILLING CODE 4184-01-P
